Literature DB >> 16177808

Low doses of delta-9 tetrahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults.

Petra Makela1, Judi Wakeley, Harm Gijsman, Phillip J Robson, Zubin Bhagwagar, Robert D Rogers.   

Abstract

Evidence suggests that manipulating spatial information within working memory depends upon a circuitry organized around the prefrontal cortex (PFC) and the activity of the catecholamine systems. Other evidence attests to the effects of Delta-9 tetrahydrocannabinol (THC) on short-term spatial memory function, most probably involving CB(1) receptor activity within hippocampal circuitries. At the current time, there have been no systematic studies of the effects of THC on spatial working memory in human subjects using tasks known to depend upon frontotemporal neural circuitries. We examined the effects of a single sublingual 5 mg dose of THC on a test of spatial working memory (requiring active manipulation of remembered spatial information for the management of future behavior) and a test of spatial span (requiring only the reproduction of sequences of previously presented spatial cues). In all, 19 healthy adults were administered 5 mg THC and placebo in a double-blind, placebo-controlled, within-subject, crossover design. Male participants performed more accurately than female participants. THC significantly enhanced spatial working memory performance of female participants. By contrast, male and female participants produced more intrusion errors during performance of the Spatial Span task. These results suggest that THC has relatively complex effects on spatial memory in human subjects, perhaps reflecting altered CB(1) receptor activity within frontotemporal circuits or altered activity of mesocortical dopaminergic pathways in PFC areas associated with spatial memory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16177808     DOI: 10.1038/sj.npp.1300871

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  23 in total

Review 1.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

Review 2.  Targeting the endocannabinoid system in Alzheimer's disease.

Authors:  Jeremy Koppel; Peter Davies
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 3.  Aging circadian rhythms and cannabinoids.

Authors:  Erik L Hodges; Nicole M Ashpole
Journal:  Neurobiol Aging       Date:  2019-03-25       Impact factor: 4.673

4.  Neuropsychological deficits associated with cannabis use in young adults.

Authors:  Jon E Grant; Samuel R Chamberlain; Liana Schreiber; Brian L Odlaug
Journal:  Drug Alcohol Depend       Date:  2011-09-14       Impact factor: 4.492

5.  The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.

Authors:  Dawn E Sugarman; James Poling; Mehmet Sofuoglu
Journal:  Pharmacol Biochem Behav       Date:  2010-12-21       Impact factor: 3.533

6.  Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat.

Authors:  Lauren C Harte; Diana Dow-Edwards
Journal:  Neurotoxicol Teratol       Date:  2010-05-09       Impact factor: 3.763

7.  Sex, drugs, and cognition: effects of marijuana.

Authors:  Beth M Anderson; Matthew Rizzo; Robert I Block; Godfrey D Pearlson; Daniel S O'Leary
Journal:  J Psychoactive Drugs       Date:  2010-12

8.  Marijuana primes, marijuana expectancies, and arithmetic efficiency.

Authors:  Joshua A Hicks; Sarah L Pedersen; Denis M McCarthy; Ronald S Friedman
Journal:  J Stud Alcohol Drugs       Date:  2009-05       Impact factor: 2.582

Review 9.  Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences.

Authors:  Natania A Crane; Randi Melissa Schuster; Paolo Fusar-Poli; Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2012-11-06       Impact factor: 7.444

10.  Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.

Authors:  Alan M Roloff; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2008-12-31       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.